JULY UPDATE: New indications for six drugs prescribers and pharmacists should know aboutCheck out these new indications for six drugs as part of our July drug news roundup. NEW DRUG: Tecentriq SC for multiple cancer typesGet the info you need on this new product, part of our drug news roundup for July. NEW DRUG: Ondexxya for rapid reversal of anticoagulation Get the info you need on this new product, part of our drug news roundup for July. NEW DRUG: Doptelet for severe and chronic thrombocytopenia Get the info you need on this new product, part of our drug news roundup for July. NEW DRUG: Velsipity for ulcerative colitis Get the info you need on this new product, part of our drug news roundup for July. Methylphenidate ER chewable tablets now available for ADHD treatment Quillivant ER (methylphenidate HCl extended-release) chewable tablets are now available for treatment of attention deficit hyperactivity disorder in children ages six to 12. McGill-led study uncovers possible drug treatment for anorexia nervosa A ‘controversial’ drug designed to treat dementia is showing promising results as a potential option for eating disorder patients. NEW DRUG: Truqap for breast cancer Get the info you need on this new product, part of our drug news roundup for July. NEW DRUG: Myalepta for leptin deficiency Get the info you need on this new product, part of our drug news roundup for July. RECALL: Teva-Ectosone lot Teva Canada is recalling a lot of Teva-Ectosone after it found unacceptably high levels of an impurity in it. First Previous 37 38 39 40 41 Next Last
